A REVERSE PHASE ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY-PHOTO DIODE ARRAY ESTIMATION OF CAPTOPRIL AND HYDROCHLOROTHIAZIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM

M. MANORANJANI; SATYADEV T. N. V. S. S.; M. DAVID RAJU

doi:10.22159/ijap.2024v16i4.49857

Authors

M. MANORANJANI Department of Chemistry, P B Siddhartha College of Arts and Science, Vijayawada, AP, India https://orcid.org/0000-0002-0639-4309
SATYADEV T. N. V. S. S. Department of Chemistry, P B Siddhartha College of Arts and Science, Vijayawada, AP, India https://orcid.org/0000-0003-1673-9611
M. DAVID RAJU Department of Chemistry, P B Siddhartha College of Arts and Science, Vijayawada, AP, India

DOI:

https://doi.org/10.22159/ijap.2024v16i4.49857

Keywords:

Isocratic method, Development, Validation, RP-UPLC, Stability indicating

Abstract

Objective: This investigation demonstrates a stability-indicating and reliable “Reverse Phase Ultra-Performance Liquid Chromatography (RP-UPLC)” method to simultaneously quantify Hydrochlorothiazide (HCTZ) and Captopril in the pharmaceutical dosage form.

Methods: Hydrochlorothiazide and Captopril were separated by using C₁₈ column (100 mm x 2.1 mm, 1.7μm) with an isocratic type of elution using mobile phase containing Acetonitrile+0.1% formic acid buffer (60:40), respectively with 0.2 ml/min flow rate. The wavelength used to detected at 210 nm to quantify Hydrochlorothiazide and Captopril.

Results: Captopril and Hydrochlorothiazide peaks were eluted with fine resolution at retention times 0.772 min and 1.679 min, respectively. In 5-30 μg/ml concentration ranges for each Captopril and Hydrochlorothiazide, the calibration graphs were linear, with regression coefficients of 0.9998 and 0.9995, respectively. The suggested Ultra-performance liquid chromatography approach has been shown as sensitive, precise, robust, accurate, specific and stability, indicating through the resolution of Captopril and Hydrochlorothiazide from its degradation-based compounds.

Conclusion: The established ultra-performance liquid chromatography technique was effectively extended to the evaluation of Captopril and Hydrochlorothiazide in the pharmaceutical dosage form, and the test results appeared satisfactory.

Downloads

Download data is not yet available.

References

Delanghe JR, Speeckaert MM, De Buyzere ML. The host’s angiotensin-converting enzyme polymorphism may explain epidemiological findings in COVID-19 infections. Clin Chim Acta. 2020;505:192-3. doi: 10.1016/j.cca.2020.03.031, PMID 32220422.

Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801-12. doi: 10.1016/S0140-6736(14)61468-9, PMID 25832858.

Vidt DG, Bravo EL, Fouad FM. Drug therapy captopril. N Engl J Med. 1982;306(4):214-9. doi: 10.1056/NEJM198201283060405, PMID 7033784.

Thibodeau JT, Drazner MH. The role of the clinical examination in patients with heart failure. JACC Heart Fail. 2018;6(7):543-51. doi: 10.1016/j.jchf.2018.04.005. PMID 29885957.

Finsterer J, Mahjoub SZ. Fatigue in healthy and diseased individuals. Am J Hosp Palliat Care. 2014;31(5):562-75. doi: 10.1177/1049909113494748, PMID 23892338.

Blessberger H, Lewis SR, Pritchard MW, Fawcett LJ, Domanovits H, Schlager O. Perioperative beta-blockers for preventing surgery-related mortality and morbidity in adults undergoing non-cardiac surgery. Cochrane Database Syst Rev. 2019;9(9):CD013438. doi: 10.1002/14651858.CD013438, PMID 31556094.

Jiaying Z, Ning C, Muke Z, Jian G. Calcium channel blockers versus other classes of drugs for hypertension. Cochrane Database Syst Rev. 2021;2021:pub5:CD003654:CD003654. doi: 10.1002/14651858.

Kovesdy CP. Updates in hyperkalemia: outcomes and therapeutic strategies. Rev Endocr Metab Disord. 2017;18(1):41-7. doi: 10.1007/s11154-016-9384-x, PMID 27600582.

Kovesdy CP. Management of hyperkalemia: an update for the internist. Am J Med. 2015;128(12):1281-7. doi: 10.1016/j.amjmed.2015.05.040, PMID 26093176.

Modin A, Bjorne H, Herulf M, Alving K, Weitzberg E, Lundberg JO. Nitrite-derived nitric oxide: a possible mediator of ’acidic-metabolic’ vasodilation. Acta Physiol Scand. 2001;171(1):9-16. doi: 10.1046/j.1365-201X.2001.00771.x, PMID 11350258.

Mustafic H, Jabre P, Caussin C, Murad MH, Escolano S, Tafflet M. Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA. 2012;307(7):713-21. doi: 10.1001/jama.2012.126, PMID 22337682.

Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389(10065):197-210. doi: 10.1016/S0140-6736(16)30677-8, PMID 27502078.

de Boer IH. A new chapter for diabetic kidney disease. N Engl J Med. 2017;377(9):885-7. doi: 10.1056/NEJMe1708949, PMID 28854097.

Gabriel M, Sharma V. Antidepressant discontinuation syndrome. CMAJ. 2017;189(21):E747. doi: 10.1503/cmaj.160991, PMID 28554948.

Jakobsen JC, Gluud C, Kirsch I. Should antidepressants be used for major depressive disorder? BMJ Evid Based Med. 2020;25(4):130. doi: 10.1136/bmjebm-2019-111238, PMID 31554608.

Attoub S, Gaben AM, Al-Salam S, Al Sultan MA, John A, Nicholls MG. Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann N Y Acad Sci. 2008;1138:65-72. doi: 10.1196/annals.1414.011, PMID 18837885.

Blackmond DG. The origin of biological homochirality. Cold Spring Harb Perspect Biol. 2019;11(3):a032540. doi: 10.1101/cshperspect.a032540.

Brem J, van Berkel SS, Zollman D, Lee SY, Gileadi O, McHugh PJ. Structural basis of metallo-β-lactamase inhibition by captopril stereoisomers. Antimicrob Agents Chemother. 2016;60(1):142-50. doi: 10.1128/AAC.01335-15, PMID 26482303.

Rotondo CM, Wright GD. Inhibitors of metallo-β-lactamases. Curr Opin Microbiol. 2017;39:96-105. doi: 10.1016/j.mib.2017.10.026, PMID 29154026.

Bianic F, Guelfucci F, Robin L, Martre C, Game D, Bockenhauer D. Epidemiology of distal renal tubular acidosis: a study using linked UK primary care and hospital data. Nephron. 2021;145(5):486-95. doi: 10.1159/000516876, PMID 34198293.

Clericetti CM, Milani GP, Lava SA, Bianchetti MG, Simonetti GD, Giannini O. Hyperammonemia associated with distal renal tubular acidosis or urinary tract infection: a systematic review. Pediatr Nephrol. 2018;33(3):485-91. doi: 10.1007/s00467-017-3829-7, PMID 29134448.

Vongpatanasin W. Hydrochlorothiazide is not the most useful nor versatile thiazide diuretic. Curr Opin Cardiol. 2015;30(4):361-5. doi: 10.1097/HCO.0000000000000178, PMID 26049382.

Roush GC, Messerli FH. Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects. J Hypertens. 2021;39(6):1254-60. doi: 10.1097/HJH.0000000000002771, PMID 33470735.

Wright JM, Musini VM, Gill R. First-line drugs for hypertension. Cochrane Database Syst Rev. 2018;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3, PMID 29667175.

Balcı AK, Koksal O, Kose A, Armagan E, Ozdemir F, Inal T. General characteristics of patients with electrolyte imbalance admitted to emergency department. World J Emerg Med. 2013;4(2):113-6. doi: 10.5847/wjem.j.issn.1920-8642.2013.02.005, PMID 25215103.

Bockenhauer D, Zieg J. Electrolyte disorders. Clin Perinatol. 2014;41(3):575-90. doi: 10.1016/j.clp.2014.05.007, PMID 25155728.

Shekelle PG, Newberry SJ, Fitzgerald JD, Motala A, O’Hanlon CE, Tariq A. Management of gout: a systematic review in support of an American college of physicians clinical practice guideline. Ann Intern Med. 2017;166(1):37-51. doi: 10.7326/M16-0461, PMID 27802478.

Beyl RN Jr, Hughes L, Morgan S. Update on importance of diet in gout. Am J Med. 2016;129(11):1153-8. doi: 10.1016/j.amjmed.2016.06.040, PMID 27452679.

Duarte JD, Cooper DeHoff RM. Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics. Expert Rev Cardiovasc Ther. 2010;8(6):793-802. doi: 10.1586/erc.10.27, PMID 20528637.

Choppella V, Badipati RB, Badipati S, Gonthina H, Chukka VK. Stability indicating method development and validation for simultaneous quantification of sorafenib and regorafenib drug subtances by using RP-UPLC. Int J Curr Pharm Sci. 2020;12:56-62. doi: 10.22159/ijcpr.2020v12i1.36832.

Ashok G, Mondal S. Stability-indicating method development and validation for the estimation of cabozantinib in pharmaceutical dosage forms by ultra-performance liquid chromatography. Asian J Pharm Clin Res. 2018;11(10):238-41. doi: 10.22159/ajpcr.2018.v11i10.27409.

International conference on harmonization. ICH harmonized tripartite guideline. Validation of analytical procedures: Text and methodology Q2(R1); 2005.

International conference for harmonization. ICH harmonised tripartite guideline. Impurities New Drug Prod. Vol. Q3B(R2); 2006.

Vijayakumari M, Reddy Ch B. Stability indicating validated HPLC method for the determination of zanubrutinib in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2020;13:159-62.

Rajakumari R, Sreenivasa Rao S. Stress degradation studies and development of a validated RP-HPLC method for determination of tiagabine in the presence of its degradation products. Int J Pharm Pharm Sci. 2016;8:230-6.

International conference for harmonization. ICH harmonised tripartite guideline. Impurities New Drug Prod. Vol. Q3B(R2); 2006.

Sukanya B, Mohan Goud V, Anitha P. Stability indicating ultra-performance liquid chromatography method development and validation for simultaneous estimation of artemether and lumefantrine in bulk and pharmaceutical dosage form. J Drug Delivery Ther. 2019;9(2):217-21. doi: 10.22270/jddt.v9i2.2408.

Tabassum R, Rizwan SH. Stability indicating analytical method development and validation for the estimation of ruxolitinib in bulk and pharmaceutical dosage form using UPLC. Int J Pharm Pharm Sci. 2022;15:40-6. doi: 10.22159/ijpps.2023v15i2.46839.

Alumuri T, Amarababu NL, Kurnool A, Kanuparthy PR, Merugu K. Development and validation of a stability indicating related substances of atenolol and nitrendipine by RP-HPLC. Int J App Pharm. 2022;14:265-73. doi: 10.22159/ijap.2022v14i4.44531.

Sesharao M, Madhavarao V. A new validated simultaneous reversed-phase high-performance liquid chromatography assay method for estimation of two flavones (baicalein and chrysin) in api drugs. Asian J Pharm Clin Res. 2018;11(1). doi: 10.22159/ajpcr.2018.v11i1.21174.

Murugesan A, Mathrusri AM. Simple quantified and validated stability indicating stress degradation studies of oral antidiabetic agent dapagliflozin by RP-HPLC method. Int J Appl Pharm. 2022;14:231-7.

Naresh P, Kumar KV. Leflunomide tablet formulation: development and validation of an RP-HPLC technique. Int J Pharm Pharm Sci. 2022;15(1):16-21. doi: 10.22159/ijpps.2023v15i1.46505.

Rao N, Gawde KD. Method development and force degradation studies for simultaneous estimation of salbutamol sulfate, etofylline and bromhexine hydrochloride in pharmaceutical dosage form using reversed-phase high-performance liquid chromatography method. Asian J Pharm Clin Res. 2018;11(8):378. doi: 10.22159/ajpcr.2018.v11i8.26119.

Reddy CS, Rao BT. Development and validation of a stability indicating related substances of trandolapril by RP-HPLC and its degradation. Int J App Pharm. 2021;13:115-21. doi: 10.22159/ijap.2021v13i5.42113.

Athavia BA, Dedania ZR, Dedania RR, Swamy SM, Prajapati CB. Stability indicating HPLC method for determination of vilazodone hydrochloride. Int J Curr Pharm Sci. 2017;9(4). doi: 10.22159/ijcpr.2017v9i4.20975.

Raziq A. Syed Umer Jan. Relative comparison of stability and degradation of methylcobalamine tablets of different brands at different storage settings. Int J Appl Pharm. 2021;13:171-5.

Rajakumari R, Sreenivasa Rao S. Stress degradation studies and development of a validated RP-HPLC method for determination of tiagabine in presence of its degradation products. Int J Pharm Pharm Sci. 2016;8:230-6.

Charu Pandya P, Sadhana Rajput J. Development and validation of stability indicating method RP-HPLC method of acotiamide. Int J Pharm Pharm Sci. 2018;10:1-8.

Prasada Rao PT. HPLC method development and validation of lercanidipine HCl and atenolol, characterization of its degradants by using LC-MS/MS. Int J Appl Pharm. 2022;14:125-34.

Dev ST NVSS, Chintalapudi Ramakrishna. A new related substances method development and validation of two anticancer drugs by using effective liquid chromatographic method. Int J Appl Pharm. 2022;14:116-24.

Kirschbaum J, Perlman S. Analysis of captopril and hydrochlorothiazide combination tablet formulations by liquid chromatography. J Pharm Sci. 1984;73(5):686-7. doi: 10.1002/jps.2600730524, PMID 6376768.

Ivanovic D, Medenica M, Malenovic A, Jancic BJ. Validation of the RP?HPLC method for analysis of hydrochlorothiazide and captopril in tablets. Accred Qual Assur. 2004;9(1-2):76-81. doi: 10.1007/s00769-003-0722-9.

Snyder LR, Dolan JW. Optimizing selectivity during reversed-phase high performance liquid chromatography method development: prioritizing experimental conditions. J Chromatogr A. 2013;1302:45-54. doi: 10.1016/j.chroma.2013.05.082, PMID 23830242.

Ismail R, Lee HY, Mahyudin NA, Abu Bakar F. Linearity study on detection and quantification limits for the determination of avermectins using linear regression. J Food Drug Anal. 2014;22(4):407-12. doi: 10.1016/j.jfda.2014.01.026, PMID 28911453.

Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29 Suppl 1:S49-52. PMID 18852857.

Suresh R, Anarthanan S, Manavalan R, Valliappan K. Aspects of validation in HPLC method development for pharmaceutical analysis-comparison of validation requirements by FDA, USA and ICH. Int J Pharm Sci Res. 2010;12:123-33.

Henry TR, Penn LD, Conerty JR, Wright FE, Gorman G, Pack BW. Best practices in stability indicating method development and validation for non-clinical dose formulations. AAPS J. 2016;18(6):1418-23. doi: 10.1208/s12248-016-9976-0, PMID 27600135.